诺为泰（Novotech）：2024膀胱癌：全球临床试验概况报告（英文版）（19页）.pdf

1、novotech-October 2024Bladder CancerGlobal Clinical Trial Landscape(2024)The bladder cancer treatment market ofers diverse products by companies including Alliance Pharma plc.,AstraZeneca plc.,Baxter International Inc.,and Pfizer IncMultiple ongoing Phase III trials demonstrate continued eforts to en

2、hance bladder cancer treatment through small molecule,oncolytic virus,and gene therapyCountries like the United States,Mainland China,Spain,France,the United Kingdom,Australia,and Italy emerged as top locations for conducting trialsAsia-Pacific showed faster recruitment durationsBLADDER CANCERTRIAL

3、CONTRIBUTIONSThe content of this publication is proprietary to Novotech Health Holdings.No part of this publication may be reproduced,distributed,or transmitted in any form or by any means,including photocopying,recording,or other electronic or mechanical methods,without the prior written permission

4、 of Novotech except in the case of quotations embodied in reviews and non-commercial uses.Please note that this copyright statement applies specifically to this publication and its content and does not extend to other materials or intellectual property owned by Novotech.Any unauthorized reproduction

5、 or distribution of this publication or any portion thereof may result in legal action taken by Novotech to protect its rights.For permissions or inquiries,please contact:communicationsnovotech-#DYK Did youknow?Europe had the highest incidence cases,accounting for nearly 37%of the global cases.Asia

6、had the second highest incidence,with over 215,700 cases.North America had more than 95,000 cases,followed by ROW.BLADDER CANCERGLOBAL CLINICAL TRIAL LANDSCAPE(2024)2022:GLOBALLYNEW CASES 614k8%ROW36%NORTH AMERICA31%ASIA-PACIFIC25%EUROPEBLADDERCANCER 9thIN TOTAL CANCER INCIDENCE 13thIN CANCERRELATED